Skip to main content

Photo: Discussing Parkinson’s research

Dec. 13, 2012, 9:18 AM

Jeff Balser, M.D., Ph.D., left, discusses Vanderbilt’s drug discovery program during a congressional briefing Nov. 29 in Washington, D.C.

Participating in the discussion were (seated, from left) P. Jeffrey Conn, Ph.D., director of the Vanderbilt Center for Neuroscience Drug Discovery; Todd Sherer, Ph.D., CEO of the Michael J. Fox Foundation for Parkinson’s Research; and Charles Albright, Ph.D., executive director, Neuroscience, Bristol-Myers Squibb (BMS). Vanderbilt and BMS recently announced a collaboration to develop new therapies for Parkinson’s disease, based on research supported by the Fox Foundation and the National Institutes of Health.

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice